First Look Analysts Research Calls for Monday, March 13
This report was sent to Briefing.com subscribers earlier today. https://briefing.com Upgrades: > Amgen (AMGN) upgraded to Overweight from Equal Weight at Wells Fargo; tgt lowered to $265 > Eli Lilly (LLY) upgraded to Overweight from Equal Weight at Wells Fargo;…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today. https://briefing.com
Upgrades:
> Amgen (AMGN) upgraded to Overweight from Equal Weight at Wells Fargo; tgt lowered to $265
> Eli Lilly (LLY) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $375
> JPMorgan Chase (JPM) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $155
> Moderna (MRNA) upgraded to Outperform from Market Perform at TD Cowen; tgt raised to $180
> SAGE Therapeutics (SAGE) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $60
Downgrades:
> Allbirds (BIRD) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $1.50
> British American Tobacco (BTI) downgraded to Neutral from Overweight at JP Morgan
> Comerica (CMA) downgraded to Hold from Buy at Odeon
> Hercules Capital (HTGC) downgraded to Underperform from Mkt Perform at Keefe Bruyette; tgt lowered to $10.50
> KeyCorp (KEY) downgraded to Hold from Buy at Odeon
> Logitech Int’l SA (LOGI) downgraded to Neutral from Outperform at Credit Suisse
> Merck (MRK) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $115
> Wells Fargo (WFC) downgraded to Hold from Buy at Odeon
Others:
> Cabot (CBT) initiated with an Outperform at Credit Suisse; tgt $94
> GE HealthCare (GEHC) initiated with an Outperform at Evercore ISI; tgt $90
Contact [email protected] for any questions or corrections.
